Baxter entered China in the 1980s and was one of the first large multinational companies to enter the Chinese healthcare market. Baxter China includes Baxter China Investment Limited, Baxter Medical Trading Limited, Jiangsu Baxter Pharmaceuticals & Biotechnology Research & Development Company, and five large joint venture and wholly-owned factories in Shanghai, Suzhou, Guangzhou and Tianjin.
Baxter China introduces the most advanced and diversified international medical products and services to China in the areas of drug infusion, nephrology, biotechnology, anesthesia and nutrition.
In early 2006, Baxter's Asia-Pacific headquarters was relocated to Shanghai, and has continued to invest in expanding the capacity of its China facilities to meet the Chinese market's demand for products in the areas of drug infusion, nephrology, and parenteral nutrition.